Polymorphisms of p53 Arg72Pro, p73 G4C14-to-A4T14 at Exon 2 and p21 Ser31Arg and the risk of non-Hodgkin's Lymphoma in Japanese

References

• Matsuo, K., Suzuki, R., Hamajima, N., Ogura, M., Kagami, Y., Taji, H., et al. (2001) "Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma", Blood, 97(10), 3205–3209.
   PubMed Web of Science ®Google Scholar
• Hishida, A., Matsuo, K., Hamajima, N., Ito, H., Ogura, M., Kagami, Y., et al. (2003) "Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma", Haematologica, 88(2), 159— 166.
   PubMed Web of Science ®Google Scholar
• Kerridge, I., Lincz, L., Scorgie, F., Hickey, D., Granter, N. and Spencer, A. (2002) "Association between xenobiotic gene poly-morphisms and non-Hodgkin's lymphoma risk", Br. J. Haematol., 118(2), 477 —481.
   Web of Science ®Google Scholar
• Miyashita, T. and Reed, J.C. (1995) "Tumor suppressor p53 is a direct transcriptional activator of the human bax gene", Cell, 80(2), 293— 299.
   Google Scholar
• Marin, MC., Hsu, B., Meyn, R.E., Donehower, L.A., el-Naggar, AK. and McDonnell, T.J. (1994) "Evidence that p53 and bc1-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis", Oncogene, 9(11), 3107 — 3112.
   PubMed Web of Science ®Google Scholar
• Kleihues, P., Schauble, B., zur Hausen, A., Esteve, J. and Ohgaki, H. (1997) "Tumors associated with p53 germline mutations: a synopsis of 91 families", Am. J. Pathol., 150(1), 1–13.
   Web of Science ®Google Scholar
• Jost, CA., Marin, M.C. and Kaelin, W.G. Jr. (1997) "p73 is a simian [correction of human] p53-related protein that can induce apoptosis", Nature, 389(6647), 191–194.
   PubMed Web of Science ®Google Scholar
• Nomoto, S., Haruki, N., Kondo, M., Konishi, H., Takahashi, T., Takahashi, T., et al. (1998) "Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers", Cancer Res., 58(7), 1380— 1383.
   PubMed Web of Science ®Google Scholar
• Ahomadegbe, J.C., Tourpin, S., Kaghad, M., Zelek, L., Vayssade, M., Mathieu, MC., et al. (2000) "Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers", Onco-gene, 19(47), 5413–5418.
   Web of Science ®Google Scholar
• Keshava, C., Frye, B.L., Wolff, M.S., McCanlies, E.C. and Weston, A. (2002) "Waf-1 (p21) and p53 polymorphisms in breast cancer", Cancer Epidemiol. Biomarkers Prey., 11(1), 127 — 130.
   Web of Science ®Google Scholar
• Imamura, J., Miyoshi, I. and Koeffler, H.P. (1994) "p53 in hematologic malignancies", Blood, 84(8), 2412–2421.
   PubMed Web of Science ®Google Scholar
• Ichikawa, A., Kinoshita, T., Watanabe, T., Kato, H., Nagai, H., Tsushita, K., et al. (1997) "Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma", N. Engl. J. Med., 337(8): 529–534.
   Google Scholar
• Kawano, S., Miller, C.W., Gombart, A.F., Bartram, CR., Matsuo, Y., Asou, H., et al. (1999) "Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation", Blood, 94(3), 1113— 1120.
   PubMed Web of Science ®Google Scholar
• Dumont, P., Leu, J.I., Della, Pietra, A.C. 3rd, George, D.L. and Murphy, M. (2003) "The codon 72 polymorphic variants of p53 have markedly different apoptotic potential", Nat. Genet., 33(3), 357— 365.
   Google Scholar
• Soulitzis, N., Sourvinos, G., Dokianakis, D.N. and Spandidos, D.A. (2002) "p53 codon 72 polymorphism and its association with bladder cancer", Cancer Lett., 179(2), 175–183.
   PubMed Web of Science ®Google Scholar
• Fan, R., Wu, MT., Miller, D., Wain, J.C., Kelsey, K.T., Wiencke, J.K., etal. (2000) "The p53 codon 72 polymorphism and lung cancer risk", Cancer Epidemiol. Biomarkers Prey., 9(10), 1037–1042.
   PubMed Web of Science ®Google Scholar
• Sjalander, A., Birgander, R., Hallmans, G., Cajander, S., Lenner, P., Athlin, L., et al. (1996) "p53 polymorphisms and haplotypes in breast cancer", Carcinogenesis, 17(6), 1313— 1316.
   PubMed Web of Science ®Google Scholar
• Andersson, S., Rylander, E., Strand, A., Sallstrom, J. and Wilander, E. (2001) "The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas", Br. J. Cancer., 85(8), 1153— 1156.
   Web of Science ®Google Scholar
• Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J.C., Valent, A., et al. (1997) "Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers", Cell, 90(4), 809–819.
   Google Scholar
• Ryan, B.M., McManus, R., Daly, JS., Carton, E., Keeling, P.W., Reynolds, J.V., et al. (2001) "A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma", Br. J. Cancer., 85(10), 1499 — 1503.
   Web of Science ®Google Scholar
• Hamajima, N., Matsuo, K., Suzuki, T., Nakamura, T., Matsuura, A., Hatooka, S., et al. (2002) "No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese", Cancer Lett., 181(1), 81 — 85.
   PubMed Web of Science ®Google Scholar
• Lukas, J., Groshen, S., Saffari, B., Niu, N., Reles, A., Wen, W.H., et al. (1997) "WAF1/Cip 1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium", Am. J. Pat ho!., 150(1), 167–175.
   PubMed Web of Science ®Google Scholar
• Hachiya, T., Kuriaki, Y., Ueoka, Y., Nishida, J., Kato, K. and Wake, N. (1999) "WAF1 genotype and endometrial cancer susceptibility", Gynecol. Oncol., 72(2), 187 — 192.
   Google Scholar
• Roh, J., Kim, M., Kim, J., Park, N., Song, Y., Kang, S., et al. (2001) "Polymorphisms in codon 31 of p21 and cervical cancer suscept-ibility in Korean women", Cancer Lett., 165(1), 59–62.
   PubMed Web of Science ®Google Scholar
• Chen, W.C., Wu, H.C., Hsu, C.D., Chen, H.Y. and Tsai, F.J. (2002) "p21 gene codon 31 polymorphism is associated with bladder cancer", Urol. Oncol., 7(2), 63–66.
   Google Scholar
• Hamajima, N., Matsuo, K., Saito, T., Hirose, K., Inoue, M., Takezaki, T., et al. (2001) "Gene-environment interactions and polymorphism studies for cancer risk in Hospital-based Epidemio-logic Research Program at Aichi Cancer Center II (HERPACC II)", Asian Pacific J. Cancer Prey., 2, 99–108.
   Google Scholar
• Hamajima, N., Saito, T., Matsuo, K., Kozaki, K., Takahashi, T. and Tajima, K. (2000) "Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping", Jpn. J. Cancer Res., 91, 865–868.
   Google Scholar
• Kawase, H., Hamajima, N., Tamakoshi, A., Wakai, K., Saito, T. and Tajima, K. (2003) "Triplex Polymerase Chain Reactions with Confronting Two-Pair Primers (PCR-CTPP) for NQ01 C609T, GSTM1 and GSTT1 Polymorphisms: a Convenient Genotyping Method", Asian Pacific J. Cancer Prey., 4(1), 67–70.
   Google Scholar
• Di, Como, CJ., Gaiddon, C. and Prives, C. (1999) "p73 function is inhibited by tumor-derived p53 mutants in mammalian cells", Mol. Cell Biol., 19(2), 1438–1449.
   PubMed Web of Science ®Google Scholar
• Davison, T.S., Vagner, C., Kaghad, M., Ayed, A., Caput, D. and Arrowsmith, C.H. (1999) "p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53", J. Biol. Chem., 274(26), 18709 — 18714.
   Web of Science ®Google Scholar
• Marin, MC., Jost, CA., Brooks, L.A., Irwin, M.S., O'Nions, J., Tidy, JA., et al. (2000) "A common polymorphism acts as an intragenic modifier of mutant p53 behaviour", Nat. Genet., 25(1), 47–54.
   PubMed Web of Science ®Google Scholar
• Pozniak, CD., Radinovic, S., Yang, A., McKeon, F., Kaplan, D. and Miller, F.D. (2000) "An anti-apoptotic role for the p53 family member, p73, during developmental neuron death", Science, 289(5477), 304— 306.
   PubMed Web of Science ®Google Scholar
• Macintyre, E., Willerford, D. and Morris, S.W. (2000) "Non-Hodgkin's Lymphoma: Molecular Features of B Cell Lymphoma", Hematology (American Society of Hematology Education Program), 180— 204.
   Google Scholar
• Kuppers, R., Klein, U., Hansmann, M.L. and Rajewsky, K. (1999) "Cellular origin of human B-cell lymphomas", N. Engl. J. Med., 341(20), 1520— 1529.
   Google Scholar
• Vanasse, G.J., Concannon, P. and Willerford, D.M. (1999) "Regulated genomic instability and neoplasia in the lymphoid lineage", Blood, 94(12), 3997–4010.
   PubMed Web of Science ®Google Scholar
• Zingg, J.M. and Jones, P.A. (1997) "Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis", Carcinogenesis, 18(5), 869–882.
   PubMed Web of Science ®Google Scholar
• Matsuo, K., Hamajima, N., Hirose, K., Inoue, M., Takezaki, T., Kuroishi, T., etal. (2001) "Alcohol, smoking, and dietary status and susceptibility to malignant lymphoma in Japan: results of a hospital-based case-control study at Aichi Cancer Center", Jpn. J. Cancer Res., 92(10), 1011–1017.
   PubMedGoogle Scholar
• Persson, B., Fredriksson, M., Olsen, K., Boeryd, B. and Axelson, O. (1993) "Some occupational exposures as risk factors for malignant lymphomas", Cancer, 72(5), 1773 — 1778.
   PubMed Web of Science ®Google Scholar
• Brown, L.M., Everett, G.D., Gibson, R., Burmeister, L.F., Schu-man, L.M. and Blair, A. (1992) "Smoking and risk of non-Hodgkin's lymphoma and multiple myeloma", Cancer Causes Control, 3(1), 49 — 55.
   PubMed Web of Science ®Google Scholar
• Kim, J.H., Bang, Y.J., Park, B.J., Yoo, T., Kim, C.W., Kim, T.Y., et al. (2002) "Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study", Jpn. J. Cancer Res., 93(5), 471–477.
   Google Scholar
• Chow, E.J. and Holly, E.A. (2002) "Blood transfusions as a risk factor for non-Hodgkin's lymphoma in the San Francisco Bay Area: a population-based study", Am. J. Epidemiol., 155(8), 725–731.
   Web of Science ®Google Scholar
• Chiu, B.C., Cerhan, J.R., Folsom, A.R., Sellers, T.A., Kushi, L.H., Wallace, R.B., et al. (1996) "Diet and risk of non-Hodgkin lymphoma in older women", JAMA, 275(17), 1315 — 1321.
   Google Scholar
• Ward, M.H., Zahm, S.H., Weisenburger, D.D., Gridley, G., Cantor, K.P., Saal, R.C., et al. (1994) "Dietary factors and non-Hodgkin's lymphoma in Nebraska (United States)". Cancer Causes Control, 5(5), 422–432.
   PubMed Web of Science ®Google Scholar
• Franceschi, S., Serraino, D., Carbone, A., Talamini, R. and La Vecchia, C. (1989) "Dietary factors and non-Hodgkin's lymphoma: a case-control study in the northeastern part of Italy", Nutr. Cancer., 12(4), 333–341.
   Web of Science ®Google Scholar
• Tavani, A., Pregnolato, A., Negri, E., Franceschi, S., Serraino, D., Carbone, A., et al. (1997) "Diet and risk of lymphoid neoplasms and soft tissue sarcomas", Nutr. Cancer, 27(3), 256–260.
   Web of Science ®Google Scholar
• Negri, E., La Vecchia, C., Franceschi, S., D'Avanzo, B. and Parazzini, F. (1991) "Vegetable and fruit consumption and cancer risk", Int. J. Cancer, 48(3), 350— 354.
   PubMed Web of Science ®Google Scholar
• Zhang, S.M., Hunter, D.J., Rosner, B.A., Giovannucci, E.L., Colditz, G.A., Speizer, F.E., et al. (2000) "Intakes of fruits, vegetables, and related nutrients and the risk of non-Hodgkin's lymphoma among women", Cancer Epidemiol. Biomarkers Prey., 9(5), 477–485.
   Web of Science ®Google Scholar
• Li, T., Lu, Z.M., Guo, M., Wu, Q.J., Chen, K.N., Xing, H.P., et al. (2002) "p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China", Cancer, 95(12), 2571 — 2576.
   PubMed Web of Science ®Google Scholar